Elena S. Koltun

2.1k total citations
19 papers, 271 citations indexed

About

Elena S. Koltun is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Elena S. Koltun has authored 19 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Elena S. Koltun's work include Protein Tyrosine Phosphatases (7 papers), Signaling Pathways in Disease (5 papers) and Ubiquitin and proteasome pathways (4 papers). Elena S. Koltun is often cited by papers focused on Protein Tyrosine Phosphatases (7 papers), Signaling Pathways in Disease (5 papers) and Ubiquitin and proteasome pathways (4 papers). Elena S. Koltun collaborates with scholars based in United States and Russia. Elena S. Koltun's co-authors include Arun K. Ghosh, Geoffrey Bilcer, Adrian L. Gill, David Wildes, Mallika Singh, Jacqueline A.M. Smith, Robert J. Nichols, Steven R. Kass, Christopher J. Schulze and Kasia Mordec and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Elena S. Koltun

19 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elena S. Koltun United States	9	178	112	60	49	21	19	271
Masatoshi Yuri Japan	10	171 1.0×	83 0.7×	32 0.5×	25 0.5×	46 2.2×	13	269
Kathleen D. Albright United States	8	197 1.1×	184 1.6×	22 0.4×	33 0.7×	25 1.2×	8	341
Kristina Forsterová Czechia	9	154 0.9×	119 1.1×	33 0.6×	26 0.5×	22 1.0×	13	289
Sina Haftchenary Canada	9	194 1.1×	197 1.8×	47 0.8×	54 1.1×	57 2.7×	25	389
Edward J. Lewis United Kingdom	5	223 1.3×	150 1.3×	36 0.6×	46 0.9×	77 3.7×	5	360
Stephanos Ioannidis United States	13	181 1.0×	123 1.1×	29 0.5×	125 2.6×	6 0.3×	20	370
Rachel Hiu Ha Ching Hong Kong	5	193 1.1×	79 0.7×	121 2.0×	54 1.1×	16 0.8×	6	415
Pengxing He China	11	328 1.8×	109 1.0×	53 0.9×	47 1.0×	56 2.7×	21	444
Tracey Colpitts United States	9	192 1.1×	75 0.7×	24 0.4×	36 0.7×	49 2.3×	14	322
Kelley E. McQueeney United States	11	249 1.4×	62 0.6×	97 1.6×	21 0.4×	17 0.8×	14	316

Countries citing papers authored by Elena S. Koltun

Since Specialization

Citations

This map shows the geographic impact of Elena S. Koltun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena S. Koltun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena S. Koltun more than expected).

Fields of papers citing papers by Elena S. Koltun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena S. Koltun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena S. Koltun. The network helps show where Elena S. Koltun may publish in the future.

Co-authorship network of co-authors of Elena S. Koltun

This figure shows the co-authorship network connecting the top 25 collaborators of Elena S. Koltun. A scholar is included among the top collaborators of Elena S. Koltun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena S. Koltun. Elena S. Koltun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Knox, John E., G. Leslie Burnett, Caroline E. Weller, et al.. (2024). Abstract ND03: Discovery of RMC-9805, an oral, covalent tri-complex KRASG12D(ON) inhibitor. Cancer Research. 84(7_Supplement). ND03–ND03. 12 indexed citations

Cregg, Jim, Yu Chi Yang, Christopher J. Schulze, et al.. (2023). Abstract ND07: Discovery of RMC-6291, a tri-complex KRASG12C(ON) inhibitor. Cancer Research. 83(7_Supplement). ND07–ND07. 4 indexed citations

Schulze, Christopher J., Jim Cregg, Kyle J. Seamon, et al.. (2022). Abstract 3598: A first-in-class tri-complex KRASG13C(ON) inhibitor validates therapeutic targeting of KRASG13Cand drives tumor regressions in preclinical models. Cancer Research. 82(12_Supplement). 3598–3598. 9 indexed citations

Nichols, Robert J., Yu Chi Yang, Jim Cregg, et al.. (2022). Abstract 3595: RMC-6291, a next-generation tri-complex KRASG12C(ON) inhibitor, outperforms KRASG12C(OFF) inhibitors in preclinical models of KRASG12C cancers. Cancer Research. 82(12_Supplement). 3595–3595. 27 indexed citations

Knox, John E., Jingjing Jiang, G. Leslie Burnett, et al.. (2022). Abstract 3596: RM-036, a first-in-class, orally-bioavailable, Tri-Complex covalent KRASG12D(ON) inhibitor, drives profound anti-tumor activity in KRASG12D mutant tumor models. Cancer Research. 82(12_Supplement). 3596–3596. 26 indexed citations

Gustafson, W. Clay, David Wildes, Meghan A. Rice, et al.. (2022). Direct targeting of RAS in pancreatic ductal adenocarcinoma with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RAS^MULTI(ON) inhibitor.. Journal of Clinical Oncology. 40(4_suppl). 591–591. 23 indexed citations

Quintana, Elsa, Christopher J. Schulze, Darienne R. Myers, et al.. (2020). Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment. Cancer Research. 80(13). 2889–2902. 69 indexed citations

Smith, Jacqueline A.M., Mallika Singh, Robert J. Nichols, et al.. (2020). Abstract 1943: SHP2 inhibition as the backbone of targeted therapy combinations for the treatment of cancers driven by oncogenic mutations in the RAS pathway. Cancer Research. 80(16_Supplement). 1943–1943. 1 indexed citations

Schulze, Christopher J., Alun Bermingham, Tiffany J. Choy, et al.. (2019). Abstract PR10: Tri-complex inhibitors of the oncogenic, GTP-bound form of KRASG12C overcome RTK-mediated escape mechanisms and drive tumor regressions in vivo. Molecular Cancer Therapeutics. 18(12_Supplement). PR10–PR10. 15 indexed citations

10.

Quintana, Elsa, Kasia Mordec, Robert J. Nichols, et al.. (2019). Abstract A103: Allosteric inhibition of SHP2 induces antitumor immunity in PD-1-sensitive tumors through modulation of both innate and adaptive mechanisms. Cancer Immunology Research. 7(2_Supplement). A103–A103. 1 indexed citations

11.

Lee, Grace J., Carlos Stahlhut, James Evans, et al.. (2019). Abstract 1322: Maximizing the therapeutic potential of SHP2 inhibition with rational combination strategies in tumors driven by aberrant RAS-MAPK signaling. Cancer Research. 79(13_Supplement). 1322–1322. 1 indexed citations

12.

Koltun, Elena S., Naing Aay, Ashutosh S. Jogalekar, et al.. (2018). Abstract 4878: RMC-4550, an allosteric inhibitor of SHP2: Synthesis, structure, and anti-tumor activity. Cancer Research. 78(13_Supplement). 4878–4878. 8 indexed citations

13.

Wildes, David, Naing Aay, Ashutosh S. Jogalekar, et al.. (2018). Abstract 4877: Allosteric inhibition of SHP2 variants containing cancer-associated activating mutations. Cancer Research. 78(13_Supplement). 4877–4877. 1 indexed citations

14.

Lis, Lev, Elena S. Koltun, Hung‐wen Liu, & Steven R. Kass. (2002). Ring Scission of Diastereomeric 4-Butylspiropentylcarbinyl Radicals as a Chemical Model for Identifying Enzyme-Catalyzed FAD Adducts Resulting from Spiropentylacetyl-CoA. Journal of the American Chemical Society. 124(7). 1276–1287. 7 indexed citations

15.

Ghosh, Arun K., Elena S. Koltun, & Geoffrey Bilcer. (2001). Tartaric Acid and Tartrates in the Synthesis of Bioactive Molecules. Synthesis. 2001(9). 1281–1301. 54 indexed citations

16.

Koltun, Elena S. & Steven R. Kass. (2000). Synthesis of Cycloocta-3,5-dien-1-ol and Cycloocta-3,5-dien-1-one: SeO2/O2 Oxidation of Dienes. Synthesis. 2000(10). 1366–1368. 3 indexed citations

17.

Koltun, Elena S. & Steven R. Kass. (2000). Synthesis and Reactivity of trans-Tricyclo[4.2.0.0^1,3]oct-4-ene. The Journal of Organic Chemistry. 65(11). 3530–3537. 6 indexed citations

18.

Koltun, Elena S. & Steven R. Kass. (2000). Rearrangement of the trans-Tricyclo[4.2.0.01,3]oct-4-enyl Skeleton. Tetrahedron. 56(17). 2591–2594. 2 indexed citations

19.

Menchikov, Leonid G., et al.. (1995). Regio- and Stereoselective Preparation of 3-Trimethylsilylallylic Alcohols by Solvolysis of 2-Trimethylsilylic Derivatives of 1-Bromo- and 1,1-Dibromocyclo-propanes in the Presence of CuSO4. Mendeleev Communications. 5(4). 135–135. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact